ImmunoGen
IMGN
#2144
Rank
$8.72 B
Marketcap
$31.23
Share price
0.00%
Change (1 day)
134.11%
Change (1 year)

ImmunoGen (IMGN) - Net assets

Net assets on the balance sheet as of September 2023 : $0.56 Billion USD

According to ImmunoGen 's latest financial reports the company has $0.56 Billion USD in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

ImmunoGen - Net assets on balance sheet (from 2001 to 2023)

Net assets by year

Year Net assets Change
2022-12-31$$0.15 B-52.14%
2021-12-31$$0.32 B263.5%
2020-12-31$$89.57 M-217.67%
2019-12-31$-$76.13 Million-793.78%
2018-12-31$$10.97 M-161.31%
2017-12-31$-$17.9 Million
2016-06-30$-$82.31 Million-334.46%
2015-06-30$$35.1 M-53.63%
2014-06-30$$75.69 M-37.87%
2013-06-30$$0.12 B45.25%
2012-06-30$$83.89 M-40.07%
2011-06-30$$0.13 B37.16%
2010-06-30$$0.10 B52.64%
2009-06-30$$66.85 M20.9%
2008-06-30$$55.29 M-5.31%
2007-06-30$$58.4 M-19.28%
2006-06-30$$72.35 M-16.69%
2005-06-30$$86.84 M-10.6%
2004-06-30$$97.13 M-5.4%
2003-06-30$$0.10 B-23.5%
2002-06-30$$0.13 B-5.78%
2001-06-30$$0.14 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Seagen
SGEN
$2.55 B 354.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$9.61 B 1,612.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$23.85 B 4,146.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$18.60 B 3,211.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$79.27 B 14,016.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$93.09 B 16,477.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$44.75 B 7,868.72%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
$86.29 B 15,266.42%๐Ÿ‡ซ๐Ÿ‡ท France